Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

被引：0
|
作者：
B. L. Langdahl
F. Marin
E. Shane
H. Dobnig
J. R. Zanchetta
M. Maricic
K. Krohn
K. See
M. R. Warner
机构：
[1] Åarhus University Hospital,Lilly Research Laboratories
[2] Åarhus Sygehus,Instituto de Investigaciones Metabólicas, School of Medicine
[3] Eli Lilly and Company,undefined
[4] Columbia University,undefined
[5] Medical University of Graz,undefined
[6] USAL University,undefined
[7] Catalina Pointe Arthritis and Rheumatology Specialists,undefined
来源：
Osteoporosis International | 2009年 / 20卷
关键词：
Alendronate; Bone biomarkers; Glucocorticoid-induced osteoporosis; PINP; Premenopausal; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2095 / 2104
页数：9
相关论文
共 50 条
  • [41] Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: A meta-analysis
    Kan, Shun-Li
    Yuan, Zhi-Fang
    Li, Yan
    Ai, Jie
    Xu, Hong
    Sun, Jing-Cheng
    Feng, Shi-Qing
    [J]. MEDICINE, 2016, 95 (25)
  • [42] Comparison of Bisphosphonates Versus Teriparatide in Therapy of the Glucocorticoid-Induced Osteoporosis (GIOP): A Meta-Analysis of Randomized Controlled Trials
    Dong, Bingzi
    Zhou, Yue
    Wang, Jun
    Li, Chengqian
    Fu, Zhengju
    Huang, Yajing
    Wang, Yangang
    Xu, Lili
    [J]. HORMONE AND METABOLIC RESEARCH, 2023, 55 (04) : 236 - 244
  • [43] Histomorphometric analysis of glucocorticoid-induced osteoporosis
    Carbonare, LD
    Bertoldo, F
    Valenti, MT
    Zenari, S
    Zanatta, M
    Sella, S
    Giannini, S
    Lo Cascio, V
    [J]. MICRON, 2005, 36 (7-8) : 645 - 652
  • [44] Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate
    Derakhshanian, Hoda
    Djalali, Mahmoud
    Djazayery, Abolghassem
    Nourijelyani, Keramat
    Ghadbeigi, Sajad
    Pishva, Hamideh
    Saedisomeolia, Ahmad
    Bahremand, Arash
    Dehpour, Ahmad Reza
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2013, 91 (05) : 380 - 385
  • [45] Prevention of Glucocorticoid-induced Osteoporosis with Alendronate or Alfacalcidol in Patients with Ophthalmologic Diseases
    Ikeda, T.
    Hamanishi, C.
    Souen, S.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S218 - S218
  • [46] Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate
    Burshell, Alan L.
    Moericke, Ruediger
    Correa-Rotter, Ricardo
    Chen, Peiqi
    Warner, Margaret R.
    Dalsky, Gail P.
    Taylor, Kathleen A.
    Krege, John H.
    [J]. BONE, 2010, 46 (04) : 935 - 939
  • [47] Glucocorticoid-induced osteoporosis
    Manelli, F
    Giustina, A
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (03): : 79 - 85
  • [48] Glucocorticoid-Induced Osteoporosis
    Buckley, Lenore
    Humphrey, Mary B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (26): : 2547 - 2556
  • [49] Glucocorticoid-Induced Osteoporosis
    Humphrey, Mary B.
    Buckley, Lenore
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (14): : 1378 - 1379
  • [50] GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    GENNARI, C
    [J]. CLINICAL ENDOCRINOLOGY, 1994, 41 (03) : 273 - 274
12345